Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?

Supplemental material

• Supplemental file 1 -

  Tables S1 (Positive and negative concordance rates of serum HBV RNA and HBV DNA at 96 weeks after NUC treatment) and S2 (Logistic regression analysis of baseline factors associated with HBeAg loss after 96-week NUC treatment in HBeAg-positive CHB patients)

  PDF, 431K

• Supplemental file 2 -

  Fig. S1 (Correlation between serum HBV RNA and serum HBsAg at baseline and between serum HBV RNA and intrahepatic cccDNA in HBeAg-4 positive CHB patients with higher and lower levels of HBsAg at baseline), S2 (Correlation between serum HBV RNA and intrahepatic cccDNA in patients with detectable and undetectable serum HBV DNA at 96 weeks after NUC treatment), and S3 (Dynamic changes of serum HBV RNA, HBV DNA, HBsAg, and HBeAg during 96-week NUC treatment)

  PDF, 450K